BioSpace News Archive

BioCapital

BioSpace Movers & Shakers, Oct. 11

Companies strengthen their leadership teams and boards of directors with these appointments.

October 10, 2019
·
6 min read
·
Alex Keown
Business

Corteva Agriscience and MicroMGx, Inc Form Collaboration to Accelerate the Development of Microbial-Based Crop Protection Products

Corteva Agriscience and MicroMGx announced a collaboration that aims to provide farmers a wider range of novel, microbial-based crop protection products.

October 10, 2019
·
3 min read
Biotech Bay

Viagra shows promise for use in bone marrow transplants

By dilating blood vessels, Viagra enhances the mobilization of blood-forming stem cells from the bone marrow so they can be collected from the blood for transplants

October 10, 2019
·
5 min read
Tomocube wins Innovation Award for HT-2 microscope

Development of the world’s first holotomographic microscope with 3D fluorescence recognised as photonics breakthrough by the 2019 Microscopy Today Innovation Award

October 10, 2019
·
4 min read
Business

Neil Singla, MD, CEO at Lotus Clinical Research, Speaks on Opioid Sparing Outcomes

Lotus Clinical Research announced that Neil Singla, MD, Chief Scientific Officer spoke at Arrowhead’s Pain & Migraine Therapeutics Summit in Washington, D.C. on Sept. 23, 2019.

October 10, 2019
·
3 min read
Drug Development

Alder BioPharmaceuticals® Announces First-in-Human Dosing in Phase 1 ALD1910 Study for Preventive Treatment of MigraineALD1910 is Alder’s first clinical candidate designed to inhibit pituitary adenylate cyclase-activating polypeptide (PACAP)

Alder BioPharmaceuticals, Inc. announced dosing of the first patient in a Phase 1 clinical study to evaluate ALD1910 as a preventive treatment for migraine.

October 10, 2019
·
7 min read
Drug Development

Principia Announces Positive Preliminary Data of PRN1008 from its Ongoing Phase 2 Part B Trial in Pemphigus

Principia Biopharma Inc. announced positive preliminary data from its Phase 2 pemphigus, open-label, trial.

October 10, 2019
·
6 min read
Business

UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases

UCB and Ra Pharmaceuticals Inc. announced their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma.

October 10, 2019
·
16 min read
Tej Kohli Foundation advocates a scalable, accessible and affordable technology solution to end corneal blindness worldwide.

Says game-changing biotechnology solutions are needed to accelerate a global mission to eradicate ‘needless’ corneal blindness.

October 10, 2019
·
5 min read
Deals

BioNTech Announces Pricing of Initial Public Offering

BioNTech SE announced the pricing of its initial public offering of 10,000,000 American Depositary Shares representing 10,000,000 ordinary shares at a public offering price of $15.00 per ADS, for gross proceeds of $150,000,000.

October 10, 2019
·
3 min read